Answers are grounded in this paper and cite their sources.
Background: The efficacy of gelatin-thrombin matrix sealants (Floseal ) for hemostasis has been well described in the field of cardiovascular surgery, but data supporting its safety and efficacy in liver surgery remains lacking. Methods: The surgical outcomes of 83 consecutive patients in whom Floseal was applied during hepatectomy were reviewed. The severity of bleeding before and after the application of Floseal was graded according to the Validated Intraoperative Bleeding (VIBe) Scale. Results: Floseal was applied to 87 sites in 83 patients, and all the patient eventually achieved complete hemostasis. Complete hemostasis was achieved using the initial application (for 2 minutes) in 100% of the patients with VIBe grade 1, 76% of those with VIBe grade 2, 20% of those with VIBe grade 3, and 0% of those with VIBe grade 4. A multivariate analysis confirmed that the VIBe bleeding grade before the application of Floseal (odds ratio, 36.0; P=0.002 per +1 point) was the only independent predictor for successful hemostasis with the initial 2 minutes after the application of Floseal . No bleeding-related complications were observed during the study period in the present population. Conclusions: Floseal showed an acceptable hemostatic ability and could be safely used in patients undergoing liver resection.
No takes yet. Share an insight, caveat, or question.
Okubo et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: